A study on postpartum metritis in Iraqi buffalo cows: bacterial causes and treatment.
The objectives of the present study were to determine the relationship between bacteriological findings, clinical signs and histopathological changes in postpartum metritis. Evaluation of the treatment efficiency of using systemic or intra-uterine infusion of antibiotics with some hormonal preparations for the treatment of postpartum metritis. Data were collected from 50 buffalo cows with history of calving of more than 1 month. All buffaloes were subjected to detailed clinical examination including external inspection, vaginoscopy and transrectal palpation of the cervix, uterus and ovaries. Swabs for bacteriology and biopsies for histopathology were collected from uterine lumen from each buffalo included in the present study. Bacteria identified using API systems following aerobic and anaerobic cultures. Vaginal mucus scored for character, odour and estimation of polymorphonuclear cells (PMNs). Treatment conducted using oxytetracycline in local intrauterine infusion or systemically with hormonal treatment including prostaglandin F2 alpha (PGF2 alpha) and oestradiol benzoate. Results revealed that the most predisposing factor for postpartum uterine infection was retained placenta and toxic puerperal metritis. The most prevalent bacteria in uterine lumen were Escherichia coli, Archanobacterium pyogenes, Bacteroides fragilis and Fusobacterium necrophorum the most prevalent bacteria in buffaloes with postpartum metritis. A. pyogenes and F. necrophorum were an important pathogens causing severe uterine inflammation as found in histopathological examinations. Buffaloes with postpartum metritis showed good clinical cure when oxytetracycline injected systemically with PGF2 alpha. Intrauterine infusion of oxytetracycline had no advantage for the treatment of uterine infection in buffalo cows with postpartum metritis. PGF2 alpha improved clinical cure of buffaloes with postpartum metritis.
Azawi
O I
OI
Department of Surgery and Obstetrics, College of Veterinary Medicine, University of Mosul, Mosul, Iraq. azawihh@yahoo.com
Omran
S N
SN
Hadad
J J
JJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000254:growth & development / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D002020:Buffaloes; D004716:Endometritis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D004717:Endometrium / Q000382:microbiology / Q000473:pathology; D004926:Escherichia coli / Q000254:growth & development / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary; D005260:Female; D007493:Iraq; D018457:Placenta, Retained / Q000473:pathology / Q000662:veterinary; D011247:Pregnancy; D011644:Puerperal Disorders / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*
D000900:Anti-Bacterial Agents